- FTC Imposes Conditions on Össur Hf’s Acquisition of College Park Industries, Inc. ( )
- Federal Trade Commission and Justice Department Announce Expedited Antitrust Procedure and Guidance for Coronavirus Public Health Efforts ( )
- FTC Imposes Conditions on Danaher Corporation’s Acquisition of GE Biopharma ( )
- FTC Submits Comment on Final Information Blocking Rule to the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology ( )
- FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus ( )
- Marketers of Pain Relief Device Settle FTC False Advertising Complaint ( )
- FTC, FDA to Hold Workshop on Promoting Competition in Markets for Biologics ( )
- FTC and Commonwealth of Pennsylvania Challenge Proposed Merger of Two Major Philadelphia-area Hospital Systems ( )
- FTC Requires Veterinary Service Providers Compassion First and National Veterinary Associates to Divest Assets in Three Local Markets ( )
- FTC Acts to Stop Two Companies from Making Unproven Bone and Joint Claims ( )
- FTC, FDA Sign Joint Statement Promoting Competition in Markets for Biologics ( )
- Statement of the FTC Chairman Regarding Announcement that Aveanna Healthcare and Maxim Healthcare Services have Terminated Their Acquisition Agreement ( )
- FTC and NY Attorney General Charge Vyera Pharmaceuticals, Martin Shkreli, and Other Defendants with Anticompetitive Scheme to Protect a List-Price Increase of More Than 4,000 Percent for Life-Saving Drug Daraprim ( )
- FTC Comments to State Legislatures in Kansas and Ohio Encourage Granting Advanced Practice Registered Nurses Full Practice Authority ( )
- Statement of Gail Levine, Deputy Director of FTC Bureau of Competition, Regarding the Announcement that Illumina Inc. has Abandoned Its Proposed Acquisition of Pacific Biosciences of California ( )
- FTC Challenges Illumina’s Proposed Acquisition of PacBio ( )
- Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc. ( )
- FTC Comment to Texas Medical Board Raises Competitive Concerns about Proposed Rule Imposing Additional Supervisory Requirements on Texas-Certified Nurse Anesthetists ( )
- FTC Submits Comment in Favor of Amendments to North Carolina’s Administrative Code that would Promote Expanded Access to Preventive Dental Services ( )
- FTC Submits Comment in Favor of Massachusetts House Bill 1869, which would Expand Scope of Practice for Podiatrists ( )
- Dental Products Distributors Benco Dental Supply Company, Patterson Companies, Inc. Decline to Appeal ALJ Decision, Making that Decision Final ( )
- FTC Commissioners Unanimously Find that Consummated Merger of Microprocessor Prosthetic Knee Companies Was Anticompetitive; Assets Must Be Unwound ( )
- FTC Approves Final Order Prohibiting Conduct by Therapist Staffing Company and Two Owners Accused of Colluding with Competitors on Compensation ( )
- FTC Sends Warning Letters to Sellers of Cosmetic Contacts: All Contact Lens Purchases Require a Prescription from a Medical Professional ( )
- FTC Amicus Brief Explains that Relevant Antitrust Markets Should be Defined in Light of the Anticompetitive Effects Alleged ( )
- New FTC Blog Post Raises Warning About Medicare Scam Peddling “Free” Back Braces ( )
- FTC and FDA Warn Florida Company Marketing CBD Products about Claims Related to Treating Autism, ADHD, Parkinson’s, Alzheimer’s, and Other Medical Conditions ( )
- FTC to Study the Impact of COPAs ( )
- FTC Announces PrivacyCon 2020 and Calls for Research Presentations ( )
- FTC Flags Potentially Unlawful TV Ads for Prescription Drug Lawsuits ( )